Patent Assignment
Reel/Frame 020110/0334
Change of Name
Recorded: 2007-11-14
Received: 2007-11-14
Pages: 12
Assignor
SCHERING AKTIENGESELLSCHAFT
Executed: 2006-12-29
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 170-178, BERLIN, DEX, D-13342, GERMANY
Covered Properties
(100)
Systems and Methods for Modular Information Extraction
Application:
11/939,794 →
Extended Use Combination Comprising Estrogens And Progestins
Application:
10/584,045 →
Chemokine Inhibiting Piperazine Derivatives and Their Use to Treat Myocarditis
Application:
11/834,366 →
Substituted Sulphoximines as TIE2 Inhibitors and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Application:
11/776,231 →
Substituted Isoxazolines, Pharmaceutical Compositions Containing Same, Methods of Preparing Same, and Uses of Same
Application:
11/776,232 →
18-Methyl-19-Norandrost-4-Ene 17, 17-Spiro Ether (18-Methyl-19-nor-20-Spirox-4-En-3-One), and Pharmaceutical Products Comprising the Same
Application:
11/769,952 →
Multi-Phase Contraceptive Preparation Based on a Natural Estrogen
Application:
11/578,771 →
Quinazoline Derivatives, Their Preparation, Their Use, and Medicaments Comprising Them
Application:
11/766,232 →
Sulfonamido-Macrocycles as TIE2 Inhibitors and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Application:
11/765,674 →
Cyanoquinoline Derivatives, Their Preparation, Their Use, and Medicaments Comprising Them
Application:
11/765,813 →
Substituted Sulfonamido-Macrocycles as TIE2 Inhibitors and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Application:
11/765,821 →
Oxo-Substituted Imidazo[1,2B]Pyridazines, Their Preparation and Use as Pharmaceuticals
Application:
11/765,638 →
Quinoline derivatives, their preparation, their use, and medicaments comprising them
Application:
11/765,683 →
Composition Comprising Antiprogestins and Pure Antiestrogens for Prophylaxis and Treatment of Hormone-Dependent Diseases
Application:
11/764,496 →
Substituted Pyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Application:
11/761,672 →
Substituted Arylpyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Application:
11/761,605 →
Sulphimides as Protein Kinase Inhibitors
Application:
11/759,479 →
Crystalline Forms of 11SS-(4-Acetylphenyl)-20,20,21,21,21-Pentafluoro-17-Hydroxy-19-Nor-17A-Pregna-4,9-Dien-3-One
Application:
11/757,118 →
Salt Sensitivity and Prevention of Hypertension with Drospirenone
Application:
11/749,592 →
Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease
Application:
11/797,898 →
Combination of an anti ED-B fibronectin domain antibody and an anti-EGFR-antibody
Application:
11/797,506 →
Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)
Application:
11/785,421 →
17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production
Application:
11/783,890 →
Combination of an anti ED-B fibronectin domain antibody and gemcitabine
Application:
11/783,285 →
Combination of an Anti-Ed - B Fibronectin Domain Antibody - Il-2 Fusion Protein and Gemcitabine
Application:
11/783,274 →
Inhibitors of soluble adenylate cyclase
Application:
11/727,168 →
Inhibitors of soluble adenylate cyclase
Application:
11/727,163 →
Inhibitors of Soluble Adenylate Cyclase
Application:
11/727,167 →
Protected 5,7-Dihydroxy-4,4-Dimethyl-3-Oxoheptanoic Acid Esters and 5,7-Dihydroxy-2-Alkyl-4,4-Dimethyl-3-Oxoheptanoci Acid Esters for the Synthesizing of Epothilone and Epothilone Derivatives and Process for the Production of These Esters
Application:
10/559,389 →
Processes and Intermediates Preparing Cysteine Protease Inhibitors
Application:
11/662,933 →
Novel Co-Modulators of Nuclear Receptors and Methods of Detecting and Treating Steroid Hormone-Dependent Diseases Using Same
Application:
11/680,075 →
Vegfr-2 and vegfr-3 inhibitory anthranilamide pyridones
Application:
11/654,643 →
Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases
Application:
11/648,891 →
Use of Film-Forming Hair Care Polymers from the Group of Polyurethanes and Pharmaceutical Preparations and Patches That Contain These Polymers
Application:
11/643,948 →
Fluorenes and carbazoles as ligands of the EP2 receptor
Application:
11/642,975 →
Sulfoximine-Substituted Pyrimidines, Processes for Production Thereof and Use Thereof as Drugs
Application:
11/642,961 →
Process for the Production of 4,4-Diphenylcyclohexanol
Application:
11/612,117 →
11BETA-Benzaldoxime Derivatives of D-Homooestra-4,9-Dien-3-Ones
Application:
11/635,076 →
Process for Recovery of Iopromide, Suitable for Pharmaceutical Purposes, from Mother Liquors
Application:
11/633,087 →
Process for the Production of Triiodotrimesic Acid
Application:
11/607,016 →
Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
Application:
11/605,472 →
Heteroaromatic sulphonamide prodrugs
Application:
11/605,482 →
Sulfamoyl Sulfonate Prodrugs
Application:
11/605,473 →
Prodrugs of Erbeta-Selective Substances, Processes for Their Preparation and Pharmaceutical Compositions Comprising These Compounds
Application:
11/604,891 →
9-Chloro-15-Deoxyprostaglandin Derivatives, Process for Their Preparation and Their Use as Medicaments
Application:
11/602,690 →
Reduction of restenosis
Application:
11/594,992 →
Treatment of HIV infection
Application:
60/856,044 →
Method of preventive on-demand hormonal contraception
Application:
11/583,143 →
Vegfr-2 and Vegfr-3 Inhibitory Anthranilamide Pyridines
Application:
11/525,091 →
Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
Application:
11/517,301 →
Nanoparticulate inclusion and charge complex for pharmaceutical formulations
Application:
11/514,323 →
Gripping Edge for a Syringe with Improved Protection Against Bursting
Application:
11/512,414 →
New Effector Conjugates, Process for Their Production and Their Pharmaceutical Use
Application:
11/509,557 →
Anti-Androgenic Pyrrolidines with Tumor-Inhibiting Action
Application:
11/500,876 →
Acyltryptophanols
Application:
11/501,228 →
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
Application:
11/500,501 →
16-Hydroxyestratrienes as selectively active estrogens
Application:
11/498,109 →
Process for the Production of 3-Oxo-Pregn-4-Ene-21, 17-Carbolactones by the Metal-Free Oxidation of 17-(3-Hydroxypropyl)-3,17-Dihydroxyandrostanes
Application:
11/490,543 →
Perfluoroalkyl-containing complexes, process for their production as well as their use
Application:
11/486,396 →
Case for Receiving a Medicament Pack, and Use Thereof
Application:
11/478,564 →
Optical Imaging of Rheumatoid Arthritis
Application:
11/476,218 →
Nonsteroidal Progesterone Receptor Modulators
Application:
11/473,336 →
Use of non-steroidal progesterone receptor modulators
Application:
11/473,337 →
Non-steroidal progesterone receptor modulators
Application:
11/473,325 →
Thiomorpholino Steroid Compounds, the Use Thereof for the Preparation of Meiosis-Regulating Medicaments and Method for the Preparation Thereof
Application:
10/566,282 →
Method for producing c1-c15 fragments of epothilones and the derivatives thereof
Application:
10/563,058 →
Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
Application:
11/449,866 →
Inhibitors of Soluble Adenylate Cyclase
Application:
11/448,140 →
Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
Application:
11/448,136 →
Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
Application:
11/447,303 →
X-ray arrangement for graphic display of an object under examination and use of the x-ray arrangement
Application:
11/446,515 →
Preparations and therapy of intrathecal inflammatory disease
Application:
11/443,440 →
Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
Application:
11/410,285 →
New Thiazolidinones Without Basic Nitrogen, Their Production and Use as Pharmaceutical Agents
Application:
11/410,284 →
Wafer comprising steroid hormones
Application:
11/391,646 →
Solid peroral contraceptive preparations
Application:
11/354,681 →
Composition for Contraception
Application:
11/388,172 →
N-Aryl-Sulfoximine-Substituted Pyrimidines as Cdk-and/or Vegf Inhibitors, Their Production and Use as Pharmaceutical Agents
Application:
11/386,111 →
Use of CDK II inhibitors for birth control
Application:
11/355,201 →
Contrast media for nuclear spin tomography with use of the overhauser effect
Application:
11/353,228 →
Microglia inhibitors for interrupting interleukin 12 and IFNgamma-mediated immune reactions
Application:
11/351,603 →
Thiazolidinones, Their Production and Use as Pharmaceutical Agents
Application:
11/345,666 →
Pyrazolopyridines and Salts Thereof, a Pharmaceutical Composition Comprising Said Compounds, a Method of Preparing Same and Use of Same
Application:
11/337,114 →
Use of cyanine dyes for the diagnosis of proliferative diseases
Application:
11/326,574 →
18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
Application:
11/321,449 →
Composition comprising an epothilone and methods for producing a composition comprising an epothilone
Application:
11/314,097 →
Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
Application:
11/312,646 →
Quinoline derivative, its use, production and pharmaceutical agents containing the latter
Application:
11/312,635 →
Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
Application:
11/312,648 →
Piperidine derivatives and their use as anti-inflammatory agents
Application:
11/305,322 →
1,2 Diarylbenzimidazoles and Their Pharmaceutical Use
Application:
11/305,521 →
Metasubstituted thiazolidinones, their manufacture and use as a drug
Application:
11/302,537 →
3-Amino-Pyrazolo[3,4B]Pyridines as Inhibitors of Protein Tyrosine Kinases, Their Production and Use as Pharmaceutical Agents
Application:
11/302,307 →
1,2 Diarylbenzimidazoles and Their Pharmaceutical Use
Application:
11/299,135 →
Haloalkyl Containing Compounds as Cysteine Protease Inhibitors
PCT:
PCTUS2005043344 ↗
Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives
Application:
11/274,895 →
Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said composition
Application:
10/522,169 →
Trimeric, Macrocyclically Substituted Halo-Benzene Derivatives
Application:
11/272,008 →
Novel Anthranilamide Pyridinureas as Vascular Endothelial Growth Factor (Vegf) Receptor Kinase Inhibitors
Application:
11/265,516 →
Novel Anthranilamide Pyridinureas as Vascular Endothelial Growth Factor (Vegf) Receptor Kinase Inhibitors
Application:
11/265,517 →